REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Dialimeda (Lithuania)

Main Activities: Ambulatory Health Care Services | General Medical and Surgical Hospitals
Secondary Activities: Offices of Physicians
Full name: UAB Dialimeda Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Dialimeda is a company in Lithuania, with a head office in Mazeikiai. It operates in the Ambulatory Health Care Services sector. It was first established on March 09, 2001. There are currently 24 (2025) people employed by UAB Dialimeda. From the latest financial highlights, UAB Dialimeda reported a net sales revenue increase of 12.57% in 2024. UAB Dialimeda’s net profit margin decreased by 0.83% in 2024.

Headquarters
J. Basanaviciaus g. 22
Mazeikiai; Telsiai county; Postal Code: LT-89217

Contact Details: Purchase the UAB Dialimeda report to view the information.

Basic Information
Total Employees:
Purchase the UAB Dialimeda report to view the information.
Registered Capital:
Purchase the UAB Dialimeda report to view the information.
Financial Auditors:
Purchase the UAB Dialimeda report to view the information.
Incorporation Date:
March 09, 2001
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Dialimeda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.57%
Total operating revenue
12.57%
Net Profit (Loss) for the Period
2.84%
Total Equity
8.84%
Net Profit Margin
-0.83%
Return on Equity (ROE)
-0.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?